← Open Payments lookup

RAYMOND CHO: Open Payments

NPI 1700859238 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$573 in 20 payments from 9 companies in 2025. Trend: 2023 $2,299 · 2024 $780 · 2025 $573

Food & beverage: $573
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.6$270
ABBVIE INC.3$74
Janssen Pharmaceuticals, Inc3$66
Otsuka America Pharmaceutical, Inc.2$44
Vanda Pharmaceuticals Inc.2$36
Otsuka Pharmaceutical Development & Commercialization, Inc.1$25
Neurocrine BioSciences, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Supernus Pharmaceuticals, Inc.1$17

Products named: COBENFY, VRAYLAR, SPRAVATO, REXULTI, FANAPT, INGREZZA, INVEGA SUSTENNA, CAPLYTA.

Industry payments across TX — which companies pay providers there.